Home30J • FRA
add
Ideaya Biosciences Inc
Previous close
€18.50
Day range
€18.60 - €18.60
Year range
€12.80 - €39.60
Market cap
1.90B USD
Avg Volume
22.00
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 13.50M | 64.43% |
Net income | -72.18M | -82.40% |
Net profit margin | — | — |
Earnings per share | -0.82 | -54.72% |
EBITDA | -83.79M | -66.24% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 692.51M | -0.90% |
Total assets | 1.10B | 14.47% |
Total liabilities | 76.51M | 191.83% |
Total equity | 1.02B | — |
Shares outstanding | 87.58M | — |
Price to book | 1.58 | — |
Return on assets | -18.97% | — |
Return on capital | -19.82% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -72.18M | -82.40% |
Cash from operations | -60.34M | -37.73% |
Cash from investing | 79.82M | 122.55% |
Cash from financing | 26.14M | -92.51% |
Net change in cash | 45.62M | 193.72% |
Free cash flow | -39.91M | -31.17% |
About
Founded
2015
Headquarters
Website
Employees
131
